106 related articles for article (PubMed ID: 10632269)
1. From the Food and Drug Administration.
Henney JE
JAMA; 2000 Jan; 283(1):46. PubMed ID: 10632269
[No Abstract] [Full Text] [Related]
2. Second stroke.
Kipp A
J Dent Hyg; 2000; 74(2):87. PubMed ID: 11334032
[No Abstract] [Full Text] [Related]
3. FDA approves new drug to reduce risk of stroke.
SoRelle R
Circulation; 2000 Jan; 101(3):E41. PubMed ID: 10645938
[No Abstract] [Full Text] [Related]
4. Noncompliance in antiplatelet trials: the AGATE trial perspective.
Serebruany VL; Hanley DF; Atar D; Ferguson JJ
Stroke; 2004 Jun; 35(6):e143. PubMed ID: 15087566
[No Abstract] [Full Text] [Related]
5. Does Aggrenox (aspirin/dipyridamole) reduce the risk of recurrent stroke to a greater degree than aspirin alone?
Hoover PL; Mold JW
J Okla State Med Assoc; 2008 May; 101(5):80-2. PubMed ID: 18678202
[No Abstract] [Full Text] [Related]
6. [Recurrence prophylaxis for stroke patients. Which platelet inhibitor combination protects best?].
MMW Fortschr Med; 2003 Jul; 145(29-30):63. PubMed ID: 12958789
[No Abstract] [Full Text] [Related]
7. Aggrenox and stress testing.
Bergmann SR
Circulation; 2001 Feb; 103(8):E50. PubMed ID: 11222491
[No Abstract] [Full Text] [Related]
8. Use of dipyridamole in patients with recent stroke or TIA.
Bernstein RA
Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
[No Abstract] [Full Text] [Related]
9. Secondary stroke prevention and antiplatelet therapy.
Horton HL
J Am Coll Cardiol; 2006 Jun; 47(12):2568; author reply 2569-70. PubMed ID: 16781394
[No Abstract] [Full Text] [Related]
10. Aspirin and dipyridamole for the secondary prevention of stroke.
Zielinski R; French L
J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
[No Abstract] [Full Text] [Related]
11. Dipyridamole plus aspirin in cerebrovascular disease.
Cohen SN
Arch Neurol; 2000 Jul; 57(7):1086-7. PubMed ID: 10892000
[No Abstract] [Full Text] [Related]
12. [Pharma-clinics. The drug of the month. Dipyridamole-acetylsalicylic acid combination (Aggrenox)].
Scheen AJ
Rev Med Liege; 2000 Oct; 55(10):957-9. PubMed ID: 11244807
[TBL] [Abstract][Full Text] [Related]
13. Aggrenox: a combination of antiplatelet drugs for stroke prevention.
Med Lett Drugs Ther; 2000 Feb; 42(1071):11-2. PubMed ID: 10725967
[No Abstract] [Full Text] [Related]
14. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke].
Haberl R
MMW Fortschr Med; 2003 May; 145 Suppl 2():98. PubMed ID: 14579496
[No Abstract] [Full Text] [Related]
15. Dipyridamole plus aspirin for stroke prevention.
Easton JD
Lancet Neurol; 2006 Jul; 5(7):553-4. PubMed ID: 16781983
[No Abstract] [Full Text] [Related]
16. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 Oct; 9(10 Suppl):13-5. PubMed ID: 11729420
[No Abstract] [Full Text] [Related]
17. Antiplatelet therapy: a neurology perspective.
Brass LM
Manag Care; 2000 May; 9(5 Suppl):15-7. PubMed ID: 11729408
[No Abstract] [Full Text] [Related]
18. Clinical trials and dipyridamole formulation selection.
Derendorf H
Cerebrovasc Dis; 2007; 23(1):72-3; author reply 73-4. PubMed ID: 17108677
[No Abstract] [Full Text] [Related]
19. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
20. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
